Proteomic Analysis of Neuroblastoma Microenvironment: Effect of the Host-Tumor Interaction on Disease Progression

Journal of Surgical Research

Volumn 156, Issue 1, 2009, Pages 116-122

  Turner, Katharyn E ^a   Kumar, Hari R ^a   Hoelz, Derek J ^a   Zhong, Xiaoling ^a   Rescorla, Frederick J ^a   Hickey, Robert J ^a   Malkas, Linda H ^a   Sandoval, John A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer progression; murine tumor model; neuroblastoma; proteomics; tumor microenvironment

Indexed keywords

ADVANCED CANCER; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CANCER TRANSPLANTATION; CONTROLLED STUDY; FEMALE; HOST; HUMAN; HUMAN CELL; IN VIVO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROENVIRONMENT; MOUSE; NEUROBLASTOMA; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; CYTOSOL; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UP-REGULATION;

EID: 68649087567     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.02.019     Document Type: Article

References (32)

1. Matthay K.K. Neuroblastoma: Biology and therapy. Oncology 11 (1997) 1857
2. Witz I.P., and Levy-Nissenbaum O. The tumor microenvironment in the post-PAGET era. Cancer Lett 242 (2006) 1
3. Cheng J.D., and Weiner L.M. Tumors and their microenvironments: Tilling the soil. Clin Cancer Res 9 (2003) 1590
4. Royds J.A., Dower S.K., Qwarnstrom E.E., et al. Response of tumor cells to hypoxia: Role of p53 and NFkB. Mol Pathol 51 (1998) 55
5. Lewis C.E., and Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res 66 (2006) 605
6. Lu H., Ouyang W., and Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 4 (2006) 221
7. Kopfstein L., and Christofori G. Metastasis: Cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 63 (2006) 449
8. Kumar H.R., Zhong X., Hoelz D.J., et al. Three-dimensional neuroblastoma cell culture: Proteomic analysis between monolayer and multicellular tumor spheroids. Pediatr Surg Int 24 (2008) 1229
9. Sutherland R.M., McCredie J.A., and Inch W.R. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst 46 (1971) 113
10. Sutherland R.M. Cell and environment interactions in tumor microregions: The multicell spheroid model. Science 240 (1988) 177
11. Abdel-Aziz W., Jiang H.Y., Hickey R.J., et al. Ara-C affects formation of cancer cell DNA synthesome replication intermediates. Cancer Chemother Pharmacol 45 (2000) 312
12. Sandoval J.A., Hoelz D.J., Woodruff H.A., et al. Novel peptides secreted from human neuroblastoma: Useful clinical tools?. J Pediatr Surg 41 (2006) 245
13. Izbicka E., and Izbicki T. Therapeutic strategies for the treatment of neuroblastoma. Curr Opin Investig Drugs 6 (2005) 1200
14. Jessani N., Niessen S., Mueller B.M., et al. Breast cancer cell lines grown in vivo: What goes in isn't always the same as what comes out. Cell Cycle 4 (2005) 253
15. Jessani N., Humphrey M., McDonald W.H., et al. Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. Proc Natl Acad Sci U S A 101 (2004) 13756
16. Parl F.F. Glutathione S-transferase genotypes and cancer risk. Cancer Lett 221 (2005) 123
17. Moyano J.V., Evans J.R., Chen F., et al. αB-crystallin is a novel onco protein that predicts poor clinical outcome in breast cancer. J Clin Invest 116 (2006) 261
18. Sueoka E., Goto Y., Sueoka N., et al. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res 59 (1999) 1404
19. Koon N., Schneider-Stock R., Sarlomo-Rikala M., et al. Molecular targets for tumor progression in gastrointestinal stromal tumors. Gut 53 (2004) 235
20. Alrawi S.J., Schiff M., Carroll R.E., et al. Aberrant crypt foci. Anticancer Res 26 (2006) 107
21. Kuramochi J., Arai T., Ikeda S., et al. High Pin1 expression is associated with tumor progression in colorectal cancer. J Surg Oncol 94 (2006) 155
22. Ayala G., Wang D., Wulf G., et al. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 63 (2003) 6244
23. Hann H.W., Lange B., Stahlhut M.W., et al. Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease. Cancer 66 (1990) 313
24. Brookes M.J., Hughes S., Turner F.E., et al. Modulation of iron transport proteins in human colorectal carcinogenesis. Gut 55 (2006) 1449
25. Tassone P., Tagliaferri P., Fulciniti M.T., et al. Novel therapeutic approaches based on the targeting of microenvironment-derived survival pathways in human cancer: Experimental models and translational issues. Curr Pharm Des 13 (2007) 487
26. Broxterman H.J., and Georgopapadakou N.H. Anticancer therapeutics: A surge of new developments increasingly target tumor and stroma. Drug Resist Update 10 (2007) 182
27. Kenny P.A., Lee G.Y., and Bissell M.J. Targeting the tumor microenvironment. Front Biosci 12 (2007) 3468
28. Wu W., Luo Y., Sun C., et al. Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms. Cancer Res 66 (2006) 970
29. Gibson T.B., Ranganathan A., and Grothey A. Randomized phase III trial results of panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer. Clin Colorectal Cancer 6 (2006) 29
30. Burtness B., Goldwasser M.A., Flood W., et al. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An Eastern Cooperative Oncology Group study. J Clin Oncol 23 (2005) 8646
31. Bi X., Lin Q., Foo T.W., et al. Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: Mechanism of tumorigenesis. Mol Cell Proteomics 5 (2006) 1119
32. Chang G.C., Liu K.J., Hsieh C.L., et al. Identification of α-enolase as an autoantigen in lung cancer: Its overexpression is associated with clinical outcomes. Clin Cancer Res 12 (2006) 5746